Moreover, quantifiable levels of serum B-cell-activating factor (BAFF, also known as BLyS and tumor necrosis factor ligand superfamily, member 13b) before rituximab treatment correlated ...

Vera’s lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that ...